Member Info for marik

Myles has done a terrific job. His general methodology is correct. I don't see him being right 100% of the time, but most of the pi in avacta know its true potential.

Before the recent release of S&S there was plenty of negativity on the tests. People were telling lth and myles that he was wrong and that the results would be a major let down. Well in this occasion the results were excellent. Now that we have the results the same people are moaning about the next thing. You can play the devils advocate and sure it has its place ;-) but its also important to acknowledge avactas achievements.

RM have a great presentation. It managed expectations and goes to show some new points. However, it is important to grasp that the results of presentation don't need spinning. When EUA and p3 results arrive the sp will react very well. I belive in facts not hype and I leave that for leave that for the day traders.

Agreed beast, it was practically a known. The presentation was well played by RM, and I think it managed immediate expectations very well.

From the recent odx tweet, i have to agree with Myles in that the at-home test will not require further tests and the current s&s is sufficient. I'm also reading that the dhsc announcement is imminent. Even if there are more than 1 tests chosen, the bottleneck for Avacta is the production capacity not anything else. Furthermore, with exceptional s&s results, Avacta have future proofed their test as they will certainly be one of the last men standing over the next few years.

On these basis, the sp could accelerate well beyond £5 per share and may well put Avacta at the centre of UK and other gov testing.

https://mobile.twitter.com/MylesMcNulty/status/1388035632816140294

The value isn't in confirming a phase 2 study, it's in what will follow. The potential for EUA has increased dramatically. That news could land at any point. Furthermore phase 3 and activ-2 are in progress and as such one would expect the sp to stabilise.

When the sp was in its 30's the sp was artificially surpressed by market makers during a sell off by Acacia. For many pi it provided an opportunity to buy extremely low with a big payout in results.

Right now the price can drop a little but it won't be like what has happened before as we don't have a massive seller. EUA, future sales, p3, activ-2 and potential buy out are all very close. For me, this will start climbing soon and the sp could be hitting very big numbers. I'm happier in than out.

GLA

I think the dots are extending in to lines and will soon join up. Avacta currently have licensed their tech out to numerous therapeutics and diagnostics companies. In the the therapeutics side they have one major phase 1 clinical trial and numerous out licensed therapies. Companies with such ground breaking assets would normally be valued at around £300m at this stage. The diagnostics side is also big and an £8bn contract would be very positive on the sp.

I'm expecting a £4.50 or £5.00 very soon (in the next few weeks) on positive contract news. Rising to £15 in the next months.

GLA

Seems like Myles could well be right with his latest tweet. Once we've confirmed the information, this could be a £7 to 8 billion over 24 months. Could well result in a huge price rise in the coming days.

I knew you couldn't read. ;)

If you can read you'll realise that it's far from agreeing with you.

Thanks Alex, the date is from October 2020 and subsequently he sold most of his holding. He did a short term buy in ncyt more recently. That wasn't and still is a loss and he later tweeted a crystalised loss.

Ncyt has had some very bad news since which has resulted in the massive drop from its high of 1100+. When or if it ever reaches those highs we will see if Myles was right to have sold out and crystalised his losses. Right now you can't draw that conclusion. Most of his other investments have been in the right ballpark and definitely better than the investors I've seen on the lse bulletin board.

Hes providing novacyt as an example. Novacyt was 695p on the 8th of April and a high of 1190p - they still haven't recovered. Most die hard Novacyt investors sold. If anything it was too late.

I've read his posts on detail and novacyt messed up. The only reason novacyt have marginally recovered is because they've hinted at a lft antigen test.

No he doesn't sell early. Novacyt made a pigs ear of their news flow and DHSC contracts.

Also he makes a great point about the rubbish innova test that is not CE marked for home use, but innova are ramping up production to 1.5bn per month. There is clearly huge potential for a while to come.

Posted by Timster well worth a listen.

https://avacta.com/preliminary-results-for-the-year-ending-31-december-2020-webinar-presentation/

Excellent post it deserves its own thread

Myles did a 10 tweet post which was very good. I'm not surprised that he places his target above £10 per share in the very near future:

https://mobile.twitter.com/MylesMcNulty/status/1386951650104037381

Thanks celtics.

Thanks Celtics

I took it to mean a very positive news re: PD.